Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Elisabeth Olliges, Bernhard Bührlen, Franz Fischer, Christoph Boesecke, Tim Kümmerle, Jochen Schneider, Simon Weidlich, Christiane Cordes, Hans Heiken, Hans-Jürgen Stellbrink, Ivanka Krznaric, Stefan Scholten, Björn Erik-Ole Jensen, Eva Wolf, Joram Ronel, Christoph D. Spinner & on behalf of the DUALIS STUDY GROUP. (2022) Health-related quality-of-life in people living with HIV after switching to dual therapy with ritonavir-boosted darunavir + dolutegravir: a DUALIS sub-study. AIDS Care 34:6, pages 698-707.
Read now
Read now
Martina Properzi, Paola Magro, Francesco Castelli & Eugenia Quiros-Roldan. (2018) Dolutegravir-rilpivirine: first 2-drug regimen for HIV-positive adults. Expert Review of Anti-infective Therapy 16:12, pages 877-887.
Read now
Read now
Jose L. Casado, Marta Monsalvo, Aurora M. Rojo, María Fontecha & Miguel A. Rodriguez-Sagrado. (2018) Dolutegravir and rilpivirine for the maintenance treatment of virologically suppressed HIV-1 infection. Expert Review of Clinical Pharmacology 11:6, pages 561-570.
Read now
Read now
Articles from other publishers (5)
Emilio Mateev, Magdalena Kondeva-Burdina, Maya Georgieva & Alexander Zlatkov. (2023) Repurposing of FDA-approved drugs as dual-acting MAO-B and AChE inhibitors against Alzheimer's disease: An in silico and in vitro study. Journal of Molecular Graphics and Modelling 122, pages 108471.
Crossref
Crossref
Wei Luo, Fen Liu, Yaohao Guo, Junjie Qiu, Jinrui Yan, Shuangliang Zhao & Bo Bao. (2023) Continuous synthesis of dolutegravir sodium crystals using liquid-gas heterogeneous microreactor. Chinese Chemical Letters 34:3, pages 107636.
Crossref
Crossref
Sulav Duwal, Laura Dickinson, Saye Khoo & Max von Kleist. (2018) Hybrid stochastic framework predicts efficacy of prophylaxis against HIV: An example with different dolutegravir prophylaxis schemes. PLOS Computational Biology 14:6, pages e1006155.
Crossref
Crossref
Matt S. Anderson, Sauzanne Khalilieh, Ka Lai Yee, Rachael Liu, Li Fan, Matthew L. Rizk, Vedangi Shah, Azra Hussaini, Ivy Song, Lisa L. Ross & Joan R. Butterton. (2016) A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir. Clinical Pharmacokinetics 56:6, pages 661-669.
Crossref
Crossref
Mark G.J. de Boer, Guido E.L. van den Berk, Natasja van Holten, Josephine E. Oryszcyn, Willemien Dorama, Daoud ait Moha & Kees Brinkman. (2016) Intolerance of dolutegravir-containing combination antiretroviral therapy regimens in real-life clinical practice. AIDS 30:18, pages 2831-2834.
Crossref
Crossref